Home › Adenoid Cystic Carcinoma
Adenoid Cystic Carcinoma clinical trials recruiting in the U.S.
11 studies for Adenoid Cystic Carcinoma are recruiting participants at sites across the United States.
Cities with the most studies
- Houston, TX7 studies
- Boston, MA6 studies
- New York City, NY5 studies
- Nashville, TN3 studies
- San Francisco, CA3 studies
By state
- California4 studies
- Florida3 studies
- Massachusetts6 studies
- Michigan3 studies
- New Jersey3 studies
- New York5 studies
- Tennessee3 studies
- Texas7 studies
Recently updated studies
A Study of the c-Kit Specific Antibody-Drug Conjugate NN3201 for Advanced and/or Metastatic Solid Tumors Known to Express c-Kit
RecruitingPhase 1
Ages 18 and older · All sexes · Updated Nov 13, 2026 · NCT06805825Docetaxel and SX-682 in Recurrent/Metastatic Head and Neck Squamous Cell Carcinoma, Salivary Gland Carcinoma, and Advanced Prostate Cancer
RecruitingPhase 1/2
Ages 18 to 120 · All sexes · Updated Nov 13, 2026 · NCT07667400VMD-928 Monotherapy and in Combination With Pembrolizumab to Treat TrkA Overexpression Driven Solid Tumors or Lymphoma
RecruitingPhase 1/2
Ages 18 to 80 · All sexes · Updated Nov 4, 2026 · NCT03556228Phase II Trial of Puxitatug Samrotecan (AZD8205) in Advanced, Recurrent or Metastatic (R/M) Aggressive Adenoid Cystic Carcinoma Subtype I (ACC-I)
RecruitingPhase 2
Ages 18 and older · All sexes · Updated Nov 2, 2026 · NCT07162480A Phase 1 Study of LNCB74 in Advanced Solid Tumors
RecruitingPhase 1
Ages 18 and older · All sexes · Updated Oct 29, 2026 · NCT06774963A Phase 2 Trial of Ivonescimab for Patients With Advanced, Metastatic Salivary Gland Cancers
RecruitingPhase 2
Ages 18 and older · All sexes · Updated Oct 21, 2026 · NCT06805617Stereotactic Body Radiotherapy (SBRT) for Early Treatment of Oligometastatic Adenoid Cystic Carcinoma: The SOLAR Trial
Recruiting
Ages 18 and older · All sexes · Updated Oct 5, 2026 · NCT04883671A Study of Enfortumab Vedotin in People With Adenoid Cystic Carcinoma
RecruitingPhase 2
Ages 18 and older · All sexes · Updated Oct 1, 2026 · NCT06891560CB-103 With Either Lenvatinib or Abemaciclib in Patients With NOTCH ACC
RecruitingPhase 1/2
Ages 18 and older · All sexes · Updated Sep 9, 2026 · NCT05774899A Study of Emiltatug Ledadotin (Emi-Le) in Participants With Solid Tumors
RecruitingPhase 1/2
Ages 18 and older · All sexes · Updated Jun 29, 2026 · NCT05377996Study of REM-422 in Patients With Recurrent, Metastatic, or Unresectable Adenoid Cystic Carcinoma
RecruitingPhase 1/2
Ages 18 and older · All sexes · Updated Jun 24, 2026 · NCT06118086From ClinicalTrials.gov, data retrieved Nov 15, 2026. Each study sets its own eligibility; the study team decides who can join.